Tumor-derived Autoantibodies Identify Malignant Pulmonary Nodules.
暂无分享,去创建一个
Paul Kinahan | Timothy W Randolph | Yuzheng Zhang | Xiaodong Zhu | A. M. Houghton | Paul Kinahan | P. Lampe | T. Randolph | Xiaodong Zhu | S. Pipavath | Paul D Lampe | J. Kargl | Yuzheng Zhang | J. Ladd | A McGarry Houghton | Kristin J Lastwika | Julia Kargl | Edward Lo | David Shelley | Jon J Ladd | Wei Wu | Sudhakar N J Pipavath | Melissa Shipley | Kristin J. Lastwika | David Shelley | Wei Wu | Melissa Shipley | Edward C Lo | K. Lastwika | Edward C. Lo
[1] D. Postma,et al. Increased activation of blood neutrophils after cigarette smoking in young individuals susceptible to COPD , 2014, Respiratory Research.
[2] P. Lampe,et al. High-Throughput Analysis of Plasma Hybrid Markers for Early Detection of Cancers , 2014, Proteomes.
[3] Sally M. Harrison,et al. Exploring the surfaceome of Ewing sarcoma identifies a new and unique therapeutic target , 2016, Proceedings of the National Academy of Sciences.
[4] Jef D. Boeke,et al. Rapid Identification of Monospecific Monoclonal Antibodies Using a Human Proteome Microarray* , 2012, Molecular & Cellular Proteomics.
[5] Yuzheng Zhang,et al. Cross-Species Antibody Microarray Interrogation Identifies a 3-Protein Panel of Plasma Biomarkers for Early Diagnosis of Pancreas Cancer , 2015, Clinical Cancer Research.
[6] S. Datta,et al. Implementation of Lung Cancer Screening in the Veterans Health Administration , 2017, JAMA internal medicine.
[7] E. Tan. Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis. , 2001, The Journal of clinical investigation.
[8] Ronald C. Walker,et al. Indeterminate Pulmonary Nodules: Risk for Having or for Developing Lung Cancer? , 2014, Cancer Prevention Research.
[9] Jinghua Lu,et al. Structural recognition and functional activation of FcγR by innate pentraxins , 2008, Nature.
[10] P. Lampe,et al. Discovery and validation of ovarian cancer biomarkers utilizing high density antibody microarrays. , 2010, Cancer biomarkers : section A of Disease markers.
[11] P. Massion,et al. The Pursuit of Noninvasive Diagnosis of Lung Cancer , 2016, Seminars in Respiratory and Critical Care Medicine.
[12] A. M. Houghton,et al. Neutrophils dominate the immune cell composition in non-small cell lung cancer , 2017, Nature Communications.
[13] Caroline Dive,et al. Progress and prospects of early detection in lung cancer , 2017, Open Biology.
[14] S. Justesen,et al. Wildtype p53-specific Antibody and T-Cell Responses in Cancer Patients , 2011, Journal of immunotherapy.
[15] L. Luo,et al. Role of leucine-rich repeat proteins in the development and function of neural circuits. , 2011, Annual review of cell and developmental biology.
[16] S. Hanash,et al. The Emerging Role of B Cells in Tumor Immunity. , 2016, Cancer research.
[17] J. Delrow,et al. Use of high density antibody arrays to validate and discover cancer serum biomarkers , 2007, Molecular oncology.
[18] Zhen Liu,et al. DAL-1 attenuates epithelial-to mesenchymal transition in lung cancer , 2015, Journal of experimental & clinical cancer research : CR.
[19] N. Reguart,et al. Immune checkpoint inhibitors in non-small cell lung cancer (NSCLC): Approaches on special subgroups and unresolved burning questions. , 2018, Cancer treatment reviews.
[20] P. Lampe,et al. High-throughput screening for native autoantigen-autoantibody complexes using antibody microarrays. , 2013, Journal of proteome research.
[21] David J Weber,et al. S100 proteins in cancer , 2015, Nature Reviews Cancer.
[22] S. Albelda,et al. CAR T Cell Therapy for Solid Tumors. , 2017, Annual review of medicine.
[23] S. Hanash,et al. Protein and glycomic plasma markers for early detection of adenoma and colon cancer , 2016, Gut.
[24] J. Stave,et al. Discovery of sialyl Lewis A and Lewis X modified protein cancer biomarkers using high density antibody arrays. , 2014, Journal of proteomics.
[25] Lisa M. Schwartz,et al. Patients’ Knowledge, Beliefs, and Distress Associated with Detection and Evaluation of Incidental Pulmonary Nodules for Cancer: Results from a Multicenter Survey , 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[26] C. Gatsonis,et al. Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening , 2012 .
[27] Terry Speed,et al. Normalization of cDNA microarray data. , 2003, Methods.
[28] A. M. Houghton,et al. Chronic Obstructive Pulmonary Disease Alters Immune Cell Composition and Immune Checkpoint Inhibitor Efficacy in Non‐Small Cell Lung Cancer , 2017, American journal of respiratory and critical care medicine.
[29] S. Fedewa,et al. Cancer screening in the United States, 2017: A review of current American Cancer Society guidelines and current issues in cancer screening , 2017, CA: a cancer journal for clinicians.